FDA Inspection 1198589 — Gulf Coast Regional Blood Center- Pasadena NDC

Gulf Coast Regional Blood Center- Pasadena NDC — FEI 1677618

The FDA completed an inspection of Gulf Coast Regional Blood Center- Pasadena NDC on Feb 15, 2023 in Pasadena, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 15, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Pasadena, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.